Clinical trialNANo longer available
Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer
- Outcome
- Outcome unknown
- Phase
- NA
- Status
- No longer available
- Study type
- Expanded access
- Sites
- 0
- Sponsor
- Industry
- Results posted
- No
- Last update
- 19 April 2022
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Expanded access of Pemigatinib to treat a single patient with metastatic pancreatic cancer.